In the evolving landscape of global health, the traditional frameworks used to assess technologies are increasingly being questioned for their adequacy in addressing deep-rooted equity issues. A groundbreaking commentary by Siriram and Harris, published in the International Journal for Equity in Health, boldly advocates moving beyond the conventional notion of cost-effectiveness in health technology assessments (HTA), especially within South Africa and other low- and middle-income countries (LMICs). This work challenges the global health community to rethink how technologies are evaluated, emphasizing equity at the core of decision-making processes.
Health technology assessment has long been a pivotal tool in guiding resource allocation by systematically evaluating the economic, clinical, and social impacts of health interventions. However, Siriram and Harris’s reflection highlights a crucial blind spot: while cost-effectiveness has dominated HTA, it frequently overlooks the layered disparities etched by social determinants, infrastructure limitations, and cultural contexts unique to LMICs. The commentary posits that to foster true health justice, HTA must transcend these economic boundaries and incorporate nuanced equity considerations.
South Africa stands as a focal example in their analysis, representing both the strides and struggles in implementing HTA frameworks that honor equity. The country’s diverse socioeconomic landscape and stark health disparities create a complex environment where uniform cost-effectiveness thresholds find little purchase. Siriram and Harris argue that without a shift toward equity-informed evaluations, new health technologies risk reinforcing, if not exacerbating, existing inequalities by benefit distribution skewed toward more privileged populations.
Central to the authors’ thesis is the proposition of adapting global HTA methodologies to be reflexive and locally responsive rather than prescriptive and generic. Traditional models, often born in high-income contexts, fail to resonate with the health challenges and priorities in LMIC settings. Instead, they propose embedding participatory approaches that incorporate voices from marginalized communities, health workers, and policymakers directly affected by these decisions. This inclusive engagement enriches the evaluative criteria, allowing for more culturally and socially attuned technology assessments.
Moreover, the commentary emphasizes methodological innovation. Integrating equity demands multidimensional models capable of capturing facets such as geographic accessibility, gender disparities, and socioeconomic status impacts on health outcomes. Conventional numeric thresholds and utility measurements, as argued, are insufficient to encapsulate these complex realities. Siriram and Harris suggest incorporating qualitative data alongside quantitative metrics, forging a more holistic understanding of a technology’s value beyond mere cost-to-benefit ratios.
Another pivotal feature of their argument concerns addressing the structural determinants that hinder equitable healthcare delivery, such as systemic poverty, infrastructural weaknesses, and historic marginalization. They argue that technology alone cannot bridge these gaps if HTA fails to account for the social milieu into which these technologies are deployed. Thus, equity-oriented assessment frameworks must evaluate not only efficacy and efficiency but also the capacity of health systems and communities to absorb and sustain the benefits.
Siriram and Harris also illuminate the ethical dimensions intertwined with adapting HTA for equity. Decision-making processes must align with principles of fairness and distributive justice, ensuring that marginalized groups are not left behind in the wave of technological advancement. This ethical imperative requires transparency about the trade-offs involved and explicit mechanisms to protect vulnerable populations from potential unintended consequences of new technologies.
In practical terms, integrating equity into HTA in LMICs necessitates building local capacity. Siriram and Harris underscore the importance of investing in training and institutional frameworks that empower local stakeholders to conduct and interpret assessments with an equity lens. This strategy reduces reliance on imported models and fosters ownership, leading to decision-making processes better aligned with national health priorities and sociocultural realities.
Policy implications arising from their commentary are profound. National governments, international donors, and global health organizations must recalibrate funding and support structures to prioritize equity-driven HTA reforms. This includes encouraging research that probes the intersection of technology, equity, and health outcomes, as well as reformulating guidelines and standards used worldwide to acknowledge diversity in health needs and contexts.
The commentary does not suggest discarding cost-effectiveness but rather repositioning it within a broader evaluative framework where economic efficiency coexists with social justice goals. This dual approach could prevent the marginalization of technologies that may be less cost-effective in narrow terms but crucial for reducing health disparities and improving population well-being within disadvantaged groups.
Siriram and Harris’s reflections are particularly timely amid the global health spotlight on pandemic preparedness, digital health expansion, and the pursuit of universal health coverage. These contexts amplify the stakes of equitable technology allocation and prompt urgent conversations about the frameworks guiding these critical decisions. The authors’ call for adaptive, equity-sensitive HTA models may well define the future trajectory of ethical global health innovation.
Their commentary ultimately serves as a clarion call to policymakers, researchers, and practitioners alike: equity is not a peripheral concern but the very foundation upon which health technologies must be assessed if the goal is health systems that serve all, especially the underserved. As South Africa and other LMICs navigate their unique health challenges, embedding equity within HTA offers a pathway towards more just, effective, and sustainable health technologies impacting millions.
In sum, the work by Siriram and Harris marks a seminal contribution to the ongoing discourse on health equity and technology assessment. By interrogating foundational assumptions and proposing practical pathways for reform, their reflective commentary invites a paradigm shift—one that could transform global health priorities and reimagine the promise of health technologies in LMICs with fairness at the center.
Subject of Research:
Adapting global health technology assessment frameworks to incorporate equity considerations, focusing on South Africa and other low- and middle-income countries (LMICs).
Article Title:
Beyond cost-effectiveness: a reflective commentary on adapting global health technology assessment for equity considerations in South Africa and other LMICs.
Article References:
Siriram, C., Harris, R. Beyond cost-effectiveness: a reflective commentary on adapting global health technology assessment for equity considerations in South Africa and other LMICs. Int J Equity Health 24, 316 (2025). https://doi.org/10.1186/s12939-025-02676-z
Image Credits: AI Generated
